PTEN gene in Cervical and Glioblastoma Cancer Cells


Marketed By :  LAP LAMBERT Academic Publishing   Sold By :  Kamal Books International  
Delivery in :  10-12 Business Days

₹ 4,835

Availability: Out of stock


Delivery :

5% Cashback on all Orders paid using MobiKwik Wallet T&C

Free Krispy Kreme Voucher on all Orders paid using UltraCash Wallet T&C
Product Out of Stock Subscription

(Notify me when this product is back in stock)

  • Product Description

Worldwide there are more than 273,000 deaths from cervical cancer each year and it accounts for 9% of female cancer deaths. Various alterations are indispensable for the development of this tumor in addition to the human papilloma virus infection. The global incidence rate of primary malignant brain tumors is 3.6 /100,000 person-year in males and 2.5 /100,000 person-year in females. The tumor suppressor gene PTEN on chromosome 10q23.3 was recently identified and found to be inactivated by mutated or epigenetic changes in several different types of human cancers and cancer cell lines. PTEN methylation occurs frequently in cervical and glioblastoma cancer cells and may be associated with focal less of PTEN Expression. Possible reasons for discrepancies of gene expression include differences in the biological effect of specific PTEN mutation. PTEN methylation and mutation of PTEN expression that suggest that mutation and methylation in PTEN play a significant role in the tumorogenesis of cervical cancer and glioblastoma cancer cells. This study might also indicate the utility of this gene is the prognostic marker or its importance in its therapeutic potential.

Product Specifications
SKU :COC68165
Country of ManufactureIndia
Product BrandLAP LAMBERT Academic Publishing
Product Packaging InfoBox
In The Box1 Piece
0 Review(s)